Prefrontal cortical abnormalities in currently depressed versus currently remitted patients with major depressive disorder
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Previous neuromorphometric investigations of major depressive disorder (MDD) have reported abnormalities in gray matter in several regions, although the results have been inconsistent across studies. Some discrepancies in the results across studies may reflect design limitations such as small sample sizes, whereas others may reflect biological variability that potentially manifests as differences in clinical course. For example, it remains unclear whether the abnormalities found in persistently depressed MDD subjects extend to or persist in patients who experience prolonged remission. The aim of the present study was to investigate gray matter (GM) differences in unmedicated, currently-depressed participants (dMDD) and unmedicated, currently-remitted (rMDD) participants with MDD compared to healthy controls (HC). The GM density and volume was compared across groups using voxel-based morphometry, a quantitative neuroanatomical technique, and high-resolution MRI images from 107 HC, 58 dMDD and 27 rMDD subjects. Relative to the HC group the dMDD group had reduced GM in the dorsal anterolateral (DALPFC), the dorsomedial (DMPFC) and the ventrolateral prefrontal cortex (VLPFC). Relative to the rMDD group the dMDD group showed reduced GM in the DALPFC, the VLPFC, the anterior cingulate cortex (ACC), the precuneus and the inferior parietal lobule. No regions were identified in which the rMDD group showed significantly lower GM compared to the HC group after p-values were corrected for the number of comparisons performed. In unmedicated patients in the depressed phase of MDD, we found evidence of morphometric abnormalities in DALPFC and in medial prefrontal cortical regions belonging to the visceromotor network. These findings, along with the absence of GM abnormalities in the remitted sample imply a possible link between greater GM tissue and better clinical outcome. Consistent with other neuroimaging and post-mortem neuropathological studies of MDD, we also found evidence of decreased white matter in patients with dMDD and rMDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Voxel-Based Morphometry—The Methods
Ashburner, J., & Friston, K. J. (2000) · NeuroImage · doi:10.1006/nimg.2000.0582 · Cited by 8,676 · cited 3×
“At the cluster level, due to the non-uniform smoothness of the VBM data (Ashburner and Friston, 2000), we used a non-stationary randomfield theory cluster size test (Hayasaka et al.”
InfluentialAshburner, J., & Friston, K. J. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.018 · Cited by 7,507 · cited 2×
“The VBM5 toolbox extends the unified segmentation approach implemented in SPM5, which integrates tissue classification, spatial normalization and intensity inhomogeneity bias correction (Ashburner and Friston, 2005).”
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 3×
“…the interpretability and generalizability of the results, particularly given previous evidence that these agents upregulate neurotrophin expression (Duman and Monteggia, 2006), contribute to neuronal remodeling (Bessa et al., 2009) and protect against gray matter loss (Lavretsky et al., 2005;…”
InfluentialSubgenual prefrontal cortex abnormalities in mood disorders
Drevets, W. C., Price, J. L., Simpson, J. R., Todd, R. D., Reich, T., Vannier, M., & Raichle, M. E. (1997) · Nature · doi:10.1038/386824a0 · Cited by 2,693 · cited 2×
“Previous studies have shown that GM volumetric reductions associated with MDD persist in the subgenual anterior cingulate cortex (sgACC) after a mean of 4 months of effective antidepressant drug treatment (Drevets et al., 1997), while other reports suggest that chronic antidepressant treatment might protect against fu…”
Self-citationDrevets, W. C., Price, J. L., & Furey, M. L. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0189-x · Cited by 2,241 · cited 2×
“We hypothesized that currently depressed patients would show GM reductions relative to healthy controls and to persistently remitted MDD subjects in brain areas involved in the extended visceromotor network of structures that supports mood regulation (Drevets et al., 2008).”
Self-citationNeurocircuitry of Mood Disorders
Price, J. L., & Drevets, W. C. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.104 · Cited by 1,606 · cited 5×
“…transmission in depression conceivably may lead to excitoxic damage and cellular loss, dendritic reshaping and consequent gray matter morphometric abnormalities, consistent with the histopathological changes identified in post mortem studies of MDD (reviewed in Price and Drevets, 2010).”
InfluentialSelf-citationRajkowska, G., Miguel-Hidalgo, J. J., Wei, J., Dilley, G., Pittman, S. D., Meltzer, H. Y., Overholser, J. C., Roth, B. L., & Stockmeier, C. A. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00041-4 · Cited by 1,477 · cited 1×
“Notably, post mortem studies of MDD found reduced glial cell number and density and reduced GABAergic interneuron density in these regions (Rajkowska et al., 1999, 2001, 2007).”
Untreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180 · cited 2×
“…and generalizability of the results, particularly given previous evidence that these agents upregulate neurotrophin expression (Duman and Monteggia, 2006), contribute to neuronal remodeling (Bessa et al., 2009) and protect against gray matter loss (Lavretsky et al., 2005; Sheline et al., 2003).”
Bessa, J. M., Ferreira, D., Melo, I., Marques, F., Cerqueira, J. J., Palha, J. A., Almeida, O. F. X., & Sousa, N. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.119 · Cited by 598 · cited 2×
“However, most of the patients (79%) enrolled in this study were receiving antidepressant drugs at the time of scanning, potentially limiting the interpretability and generalizability of the results, particularly given previous evidence that these agents upregulate neurotrophin expression (Duman and Monteggia, 2006), c…”
Rajkowska, G., O'Dwyer, G., Teleki, Z., Stockmeier, C. A., & Miguel-Hidalgo, J. J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301234 · Cited by 430 · cited 1×
“Notably, post mortem studies of MDD found reduced glial cell number and density and reduced GABAergic interneuron density in these regions (Rajkowska et al., 1999, 2001, 2007).”
Depression-Related Variation in Brain Morphology Over 3 Years: Effects of Stress?
Frodl, T. S., Koutsouleris, N., Bottlender, R., Born, C., Jäger, M., Scupin, I., Reiser, M., Möller, H.-J., & Meisenzahl, E. M. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.10.1156 · Cited by 359 · cited 8×
“Indeed, there is accumulating evidence from cross-sectional (Caetano et al., 2006; Yucel et al., 2009) and longitudinal studies (Frodl et al., 2008b; Chen et al., 2007; Costafreda et al., 2009) that GM morphometry might provide biomarkers associated with antidepressant response (Yucel et al., 2009;…”
InfluentialChen, C.-H., Ridler, K., Suckling, J., Williams, S., Fu, C. H. Y., Merlo-Pich, E., & Bullmore, E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.018 · Cited by 354 · cited 4×
“, 2009) that GM morphometry might provide biomarkers associated with antidepressant response (Yucel et al., 2009; Chen et al., 2007) and prolonged remission (Frodl et al.”
InfluentialFrodl, T., Reinhold, E., Koutsouleris, N., Reiser, M., & Meisenzahl, E. M. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.01.006 · Cited by 323
Prognostic and diagnostic potential of the structural neuroanatomy of depression
Costafreda, S. G., Chu, C., Ashburner, J., & Fu, C. H. Y. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006353 · Cited by 232 · cited 2×
“…evidence from cross-sectional (Caetano et al., 2006; Yucel et al., 2009) and longitudinal studies (Frodl et al., 2008b; Chen et al., 2007; Costafreda et al., 2009) that GM morphometry might provide biomarkers associated with antidepressant response (Yucel et al., 2009; Chen et al., 2007)…”
Angst, J., Gamma, A., Rössler, W., Ajdacic, V., & Klein, D. N. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.09.023 · Cited by 160 · cited 1×
“The chronic/ intermittent illness course generally represents a more severe and debilitating subphenotype than that associated with an episodic course with full and prolonged recovery between episodes (Angst et al., 2009).”
Circumscribed changes of the cerebral cortex in neuropsychiatric disorders of later life.
Bowen, D. M., Najlerahim, A., Procter, A. W., Francis, P. T., & Murphy, E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.23.9504 · Cited by 157 · cited 1×
“Figure) Notably, the left VLPFC (part of left inferior frontal gyrus) has been shown to contain abnormally reduced GM in depressed MDD subjects both herein (Table 3) and in previous post mortem studies (Bowen et al., 1989).”
Early adverse events, HPA activity and rostral anterior cingulate volume in MDD
Treadway, M. T., Grant, M. M., Ding, Z., Hollon, S. D., Gore, J. C., & Shelton, R. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004887 · Cited by 142 · cited 3×
“…belonging to the visceromotor network, including the orbitofrontal (OFC), subgenual prefrontal (SGPFC) and anterior cingulate cortices, and the hippocampus/amygdala complex (Tang et al., 2007; Wagner et al., 2008; Vasic et al., 2008; Leung et al., 2009; Frodl et al., 2008a; Treadway et al., 2009).”
Zou, K., Deng, W., Li, T., Zhang, B., Jiang, L., Huang, C., Sun, X., & Sun, X. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.014 · Cited by 141 · cited 1×
“According to recent evidence, hippocampal abnormalities might extend to treatment-naïve, firstepisode MDD subjects, providing further evidence of the key role of this structure in the pathophysiology of depression (Zou et al., 2010).”
Cited by
Neural circuits underlying the pathophysiology of mood disorders
Price, J. L., & Drevets, W. C. (2012) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.12.011 · Cited by 788
Self-citationBora, E., Fornito, A., Pantelis, C., & Yücel, M. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.03.049 · Cited by 763
Astrocyte Pathology in Major Depressive Disorder: Insights from Human Postmortem Brain Tissue
Rajkowska, G., & Stockmeier, C. (2013) · Current Drug Targets · doi:10.2174/13894501113149990156 · Cited by 603
“Moreover, reduced density of astrocytes may account, at least in part, for volumetric reductions reported by neuroimaging studies in the prefrontal cortex of depressed patients [43-47].”
BackgroundRadley, J., Morilak, D., Viau, V., & Campeau, S. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.06.018 · Cited by 339
State-dependent changes in hippocampal grey matter in depression
Arnone, D., McKie, S., Elliott, R., Juhasz, G., Thomas, E. J., Downey, D., Williams, S., Deakin, J. F. W., & Anderson, I. M. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.150 · Cited by 287
Metadata
- Authors
- Salvadore, G., Nugent, A. C., Lemaitre, H., Luckenbaugh, D. A., Tinsley, R., Cannon, D. M., Neumeister, A., Zarate, C. A., & Drevets, W. C.
- Venue
- NeuroImage
- Publisher
- Elsevier BV
- Published
- 2011-02
- Volume
- 54
- Issue
- 4
- Pages
- 2643-2651
- ISSN
- 1053-8119 (ISSN-L)
- OpenAlex
- W2011658741
- Cited by
- 187
- References
- 19
- FWCI
- 6.15
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.